SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Spine-Tech (SPYN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: .com who wrote (73)10/30/1996 7:05:00 PM
From: Royalcoachman   of 242
 
Hambrecht & Quist and Robertson, Stevens & Co. just reiterated a buy recomendation for SPYN today.
H&Q is estimating 36 cents for next year and R&S is estimating 77 cents for next year. Seems a bit of
a spread in the estimates. One of the analyst says that the stock is going to 45 in 18 months. He bases
his prediction on the stock selling for 35 times his 1988 earnings estimate of $1.30. This analyst is
exceptionally brilliant because he can predict with accuracy both the earnings per share and the price earnigs ratio
more than two years in advance. Furthermore, he predicts that the market will achieve a price earnings ratio
based on expected earnings. I would like to find out where this guy went to college, because I want to send my
kids to a school that can make people this smart.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext